Literature DB >> 18201940

Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.

Mark Trombetta1, Thomas Julian, Tanuja Bhandari, E Day Werts, Moyed Miften, David Parda.   

Abstract

PURPOSE: To evaluate lumpectomy followed by interstitial brachytherapy as an acceptable salvage therapy for women who have developed localized recurrence of breast cancer after conservation surgery and postoperative external radiotherapy. METHODS AND MATERIALS: Between 1/1998 and 10/2006, 21 patients with T0 or T1 in-breast recurrence of carcinoma were offered interstitial low-dose rate brachytherapy after tumor re-excision as an alternative to salvage mastectomy. All patients had failed lumpectomy followed by standard postoperative external beam radiotherapy (range, 5000-6040cGy) as treatment for the initial breast carcinoma. Seven recurred as ductal carcinoma in situ, 2 as infiltrating lobular carcinoma, and 12 as recurrent invasive carcinoma. The recurrent tumors were excised with final margins of resection free of residual disease per National Surgical Adjuvant Breast and Bowel Project definition. Tumor bed implantation was then carried out with an interstitial technique using (192)Ir with the target volume consisting of the tumor bed plus a minimum 1.0-cm clinical margin. The required minimum dose delivered to the target volume was 4500-5000cGy (range, 4500-5530).
RESULTS: Twenty of 21 patients were free of local disease with a median observation time of 40 months (range, 3-69). The single patient who developed a second local recurrence was treated successfully with simple mastectomy. Two patients succumbed to systemic disease at 17 and 24 months after salvage implant therapy. One patient developed a contralateral breast cancer. Cosmetic results defined by the National Surgical Adjuvant Breast and Bowel Project cosmesis scale were acceptable. One patient developed a localized seroma requiring multiple needle aspirations before complete resolution. Two patients developed localized skin breakdown in the tumor bed. One healed after 6 months of conservative treatment. The other healed 9 months later with Grade II cosmesis. This patient also developed a concurrent postoperative wound infection.
CONCLUSIONS: Repeat lumpectomy followed by brachytherapy is feasible and may be an acceptable alternative to salvage mastectomy in patients who locally fail conservation breast therapy; however, longer followup and greater patient numbers may be needed to better define the role of salvage brachytherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201940     DOI: 10.1016/j.brachy.2007.12.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  9 in total

1.  Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.

Authors:  Caprice C Greenberg; Laurel A Habel; Melissa E Hughes; Larissa Nekhlyudov; Ninah Achacoso; Luana Acton; Deborah Schrag; Wei Jiang; Stephen Edge; Jane C Weeks; Rinaa S Punglia
Journal:  Ann Surg Oncol       Date:  2014-05-24       Impact factor: 5.344

Review 2.  The Role of Brachytherapy in the Treatment of Breast Cancer.

Authors:  Daniela Kauer-Dorner; Daniel Berger
Journal:  Breast Care (Basel)       Date:  2018-05-29       Impact factor: 2.860

3.  High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study.

Authors:  Andrea Vavassori; Giulia Riva; Iacopo Cavallo; Ruggero Spoto; Samantha Dicuonzo; Cristiana Fodor; Stefania Comi; Raffaella Cambria; Federica Cattani; Anna Morra; Maria Cristina Leonardi; Roberta Lazzari; Mattia Intra; Alberto Luini; Viviana Enrica Galimberti; Paolo Veronesi; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2020-06-30

4.  Proton Reirradiation for Locoregionally Recurrent Breast Cancer.

Authors:  Michael J LaRiviere; Alexandra Dreyfuss; Neil K Taunk; Gary M Freedman
Journal:  Adv Radiat Oncol       Date:  2021-05-09

5.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.

Authors:  Stewart J Anderson; Irene Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Jong-Hyeon Jeong; Charles E Geyer; D Lawrence Wickerham; Joseph P Costantino; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

Review 6.  Current Treatment of Isolated Locoregional Breast Cancer Recurrences.

Authors:  Wolfgang Harms; Andreas Geretschläger; Corinne Cescato; Martin Buess; Dieter Köberle; Branca Asadpour
Journal:  Breast Care (Basel)       Date:  2015-08-21       Impact factor: 2.860

7.  Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.

Authors:  Marie Gosset; Anne-Sophie Hamy; Peter Mallon; Myriam Delomenie; Delphine Mouttet; Jean-Yves Pierga; Marick Lae; Alain Fourquet; Roman Rouzier; Fabien Reyal; Jean-Guillaume Feron
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

8.  Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients.

Authors:  Salvatore Cozzi; Dina Najjari Jamal; Andrea Slocker; Maria Laplana; Amparo Garcia Tejedor; Marco Krengli; Ferran Guedea; Cristina Gutierrez
Journal:  J Contemp Brachytherapy       Date:  2019-04-29

9.  DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.

Authors:  Wolfgang Harms; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; D Krug; M D Piroth; M-L Sautter-Bihl; F Sedlmayer; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2016-03-01       Impact factor: 3.621

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.